PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

PAR Clinical Trial - Melbourne, page-45

  1. 397 Posts.
    lightbulb Created with Sketch. 23
    Oxxa23, who knows, in 5 years from now it may well be on the PBS schemes
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.